The Maine Cancer Genomics Initiative: Implementing a Community Cancer Genomics Program Across an Entire Rural State We retrospectively analyzed a multi-institutional cohort of patients with ...
Utility of Perioperative Measurement of Cell-Free DNA and Circulating Tumor DNA in Informing the Prognosis of GI Cancers: A Systematic Review Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors have ...
MedPage Today on MSN
Overcoming CDK4/6 inhibitor resistance in HR-positive/HER2-negative breast cancer
The optimal approach to treatment in the post-CDK4/6 inhibitor setting remains undefined, but multiple strategies have ...
In this video, Halle C. F. Moore, MD, discusses the EMBER-3 study update evaluating imlunestrant for women with hormone receptor-positive, HER2-negative breast cancer, presented at San Antonio Breast ...
Dr. Blackwell is a distinguished leader in breast cancer research with a breadth of experience advancing multiple oncology programs through the clinic,” said Patrick Roberts, Pharm.D., Ph.D., Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback